From
Gwacheon-si,
Gyeonggi-do,
South Korea (Republic Of Korea)
PANCCHECK is a blood test solution that enables early diagnosis of pancreatic cancer with 94% accuracy is under development.
PANCCHECK DEVELOPMENT PROCESS:
While effective early diagnostic methods for pancreatic cancer are currently lacking, BERTIS is developing a technology that enables early diagnosis of pancreatic cancer with a small blood sample.
Through research, we have identified 10 protein biomarkers as a diagnostic marker panel for pancreatic cancer. Following algorithm development and validation, we have uncovered a combination of markers that demonstrates a high accuracy of 98% and is applicable in clinical settings.